Blog
Sealed Air Inks $10.3 Billion Agreement to Be Acquired by CD&R
Sealed Air Corporation SEE announced that it has inked a definitive agreement with CD&R to be acquired in an all-cash transaction with an enterprise value of $10.3 billion. This move is in sync with
Sea Limited Misses Q3 Estimates: Buy, Sell or Hold the Stock?
Sea Limited’s SE latest results highlight why investors should hold the stock despite its third-quarter earnings miss. The company delivered strong top-line expansion, with revenues rising 38.3%
Medpace (MEDP) is an Incredible Growth Stock: 3 Reasons Why
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a growth stock
3 Reasons Why Allstate (ALL) Is a Great Growth Stock
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)
Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth
Looking for a Growth Stock? 3 Reasons Why M/A-Com (MTSI) is a Solid Choice
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth
Here's Why Investors Should Give KNX Stock a Miss Now
Knight-Swift Transportation KNX is facing mounting pressure from increased expenses. Tariff-related woes are also hurting the company’s prospects, making it an unattractive choice for investors’
PulteGroup to Boost Footprint by Debuting in the Cincinnati Market
PulteGroup, Inc. PHM is further reinforcing its market leadership in the Midwest with plans to expand its homebuilding operations into the Cincinnati market in Ohio.Building on its strong
Vertiv Gains From AI and Data Center Growth: A Sign for More Upside?
Vertiv VRT is benefiting from the accelerating adoption of artificial intelligence (AI) and the growing demand for data centers globally. In the third quarter of 2025, Net sales increased 29% year
Dell Technologies AI Solutions Gain Momentum: A Sign for More Upside?
Dell Technologies DELL is benefiting from the growing demand for AI solutions, which has been a major growth driver for its success. In the second quarter of fiscal 2026, Dell Technologies reported
Will Amphenol's Aggressive M&A Push Unlock Its Next Growth Phase?
Amphenol APH is pursuing an aggressive acquisition strategy that is now delivering visible results. The strategy is significantly more relevant for investors evaluating the company's long-term
HIW's $223M Bet on 6Hundred at Legacy Union: Time to Buy the Stock?
Highwoods Properties HIW is setting the stage for growth with the planned acquisition of 6Hundred at Legacy Union, a newly delivered 411,000-square-foot Class AA office tower in Charlotte’s Uptown
Earnings Estimates Rising for Jamf Holding (JAMF): Will It Gain?
Jamf Holding (JAMF) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue
Earnings Estimates Rising for Allstate (ALL): Will It Gain?
Allstate (ALL) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue since its
Here's Why Investors Should Give Canadian Pacific Stock a Miss Now
Canadian Pacific Kansas City Limited CP is facing mounting pressure from increased expenses. Tariff-related woes are also hurting the company’s prospects, making it an unattractive choice for
JAZZ Hits 52-Week High on Encouraging Gastric Cancer Study Data
Shares of Jazz Pharmaceuticals JAZZ rose nearly 21% on Monday after it announced positive top-line results from the late-stage HERIZON-GEA-01 study. This study evaluated different combination
Is RS2's New Visa Status a Game-Changer for Europe's Card Market?
Visa Inc. V is making waves in Europe as Beyond by RS2 steps up to become a Principal Issuing Member, a significant milestone that enhances V’s growing presence in the region’s rapidly expanding
Why Williams-Sonoma (WSM) Could Beat Earnings Estimates Again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Williams-Sonoma (WSM), which belongs to
Beer Business Softness Deepens: Can Molson Coors Reignite Core Brands?
Molson Coors Beverage Company TAP is navigating one of the most challenging beer environments in recent years, as industry volume declines continue to weigh on overall performance. In 2025, U.S
Gorilla Technology Q3 Earnings Miss Estimates, Pipeline Increased
Gorilla Technology Group Inc. GRRR announced third-quarter 2025 adjusted EPS of 24 cents, missing the Zacks Consensus Estimate by 7.7% and decreasing 17.2% from the year-ago level.
Total revenues
Mission Produce's U.K. Hub Gains Traction: Is Europe the Next Big Bet?
Mission Produce, Inc.’s AVO growing momentum in the U.K. marks a strategic turning point for the company as it extends its avocado leadership into high-potential international markets. After years
All You Need to Know About PLBY Group (PLBY) Rating Upgrade to Buy
PLBY Group, Inc. (PLBY) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
ADC Therapeutics (ADCT) Upgraded to Buy: Here's What You Should Know
Investors might want to bet on ADC Therapeutics SA (ADCT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings
All You Need to Know About Virgin Galactic (SPCE) Rating Upgrade to Buy
Virgin Galactic (SPCE) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of
What Makes Jade Biosciences, Inc. (JBIO) a New Buy Stock
Jade Biosciences, Inc. (JBIO) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings


